Novel Nitinol Stent for Lesions up to 24 cm in the Superficial Femoral and Proximal Popliteal Arteries: 24-Month Results From the TIGRIS Randomized Trial.
about
Novel Nitinol Stent for Lesions up to 24 cm in the Superficial Femoral and Proximal Popliteal Arteries: 24-Month Results From the TIGRIS Randomized Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Novel Nitinol Stent for Lesion ...... m the TIGRIS Randomized Trial.
@en
Novel Nitinol Stent for Lesion ...... m the TIGRIS Randomized Trial.
@nl
type
label
Novel Nitinol Stent for Lesion ...... m the TIGRIS Randomized Trial.
@en
Novel Nitinol Stent for Lesion ...... m the TIGRIS Randomized Trial.
@nl
prefLabel
Novel Nitinol Stent for Lesion ...... m the TIGRIS Randomized Trial.
@en
Novel Nitinol Stent for Lesion ...... m the TIGRIS Randomized Trial.
@nl
P2093
P356
P1476
Novel Nitinol Stent for Lesion ...... om the TIGRIS Randomized Trial
@en
P2093
Alexandra Lansky
Aravinda Nanjundappa
Frank Bunch
Jack Chamberlin
John R Laird
Michael R Jaff
Peter A Schneider
Richard Begg
Scott Schultz
Stuart Harlin
P356
10.1177/1526602817749242
P577
2017-12-29T00:00:00Z